mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |